Study says US drug companies spend more on promotion

Share this content:

A study by two Canadian researchers says US drug companies spend nearly twice as much on promoting their products ($57.5 billion in 2004) than they spend on research and development ($31.5 billion in 2004). PhRMA called the contention a “myth.”

Share this content:
Scroll down to see the next article